1887
1 - Extracorporeal Life Support Organisation of the South and West Asia Chapter 2017 Conference Proceedings
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

The use of mechanical circulatory assistance remains controversial during refractory septic shock in adults.1 However, a profound myocardial dysfunction can occur during bacterial septic shock.2–4 In this context, extracorporeal membrane oxygenation (ECMO) is highly effective as salvage therapy for children with refractory septic shock.5,6 We reported the largest cohort of adults who received VA-ECMO for refractory cardiovascular dysfunction in the context of severe bacterial septic shock.5 Despite multiorgan failure at ECMO initiation and simplified acute physiology score (SAPS) 3-predicted mortality of 79%, >70% of these patients survived with complete recovery of cardiac function. The hemodynamic profile we describe herein (low cardiac index, elevated filling pressure, profound myocardial depression, and elevated systemic vascular resistance) is certainly a rare entity in the spectrum of septic shock, which resembles that of the classic paradigm of cardiogenic shock. In this setting, the infusion of very high catecholamine doses used to increase cardiac output and maintain perfusion before ECMO initiation might have contributed to the vicious circle that led to vasoconstriction and refractory cardiovascular failure. Considering the reversibility of myocardial depression associated with septic shock,7,8, we hypothesized that ECMO could help salvage these dying patients by restoring adequate perfusion to vital organs to reverse multiple organ failures and by buying time to achieve infection control by antibiotics. Indeed, all our survivors could be explanted without recourse to cardiac transplantation or switching to another cardiac assist device, and all recovered with a normal myocardial function within a few weeks. These results seem to be far better than those obtained with ECMO for cardiogenic shock, with reported survival rates around 40%, that required cardiac transplantation or switching to a LV (left ventricular) assist device for about 10% of the survivors.9 Considering these promising results, ECMO might be considered a valuable therapeutic option for patients with refractory cardiovascular dysfunction in the context of septic shock, although more data and larger patient cohorts are needed to confirm the findings presented herein. In accordance with the ethical standards of our hospital's institutional review board, the Committee for the Protection of Human Subjects, informed consent for demographic, physiologic, and hospital-outcome data analyses was not obtained because this observational study did not modify existing diagnostic or therapeutic strategies. Survivors gave oral consent to participate in the telephone interview, conducted by the same investigator, who asked the questions in the questionnaire in the same order.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2017.swacelso.24
2017-02-14
2020-10-25
Loading full text...

Full text loading...

References

  1. Cheng A, Sun HY, Tsai MS, Ko WJ, Tsai PR, Hu FC, Chen YC, Chang SC. Predictors of survival in adults undergoing extracorporeal membrane oxygenation with severe infections. J Thorac Cardiovasc Surg. 2016; 152:6:15261536.e1521.
    [Google Scholar]
  2. Kimchi A, Ellrodt AG, Berman DS, Riedinger MS, Swan HJ, Murata GH. Right ventricular performance in septic shock: A combined radionuclide and hemodynamic study. J Am Coll Cardiol. 1984; 4:5:945951.
    [Google Scholar]
  3. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984; 100:4:483490.
    [Google Scholar]
  4. Ellrodt AG, Riedinger MS, Kimchi A, Berman DS, Maddahi J, Swan HJ, Murata GH. Left ventricular performance in septic shock: Reversible segmental and global abnormalities. Am Heart J. 1985; 110:2:402409.
    [Google Scholar]
  5. Brechot N, Luyt CE, Schmidt M, Leprince P, Trouillet JL, Léger P, Pavie A, Chastre J, Combes A. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med. 2013; 41:7:16161626.
    [Google Scholar]
  6. Park TK, Yang JH, Jeon K, Choi SH, Choi JH, Gwon HC, Chung CR, Park CM, Cho YH, Sung K, Suh GY. Extracorporeal membrane oxygenation for refractory septic shock in adults. Eur J Cardiothorac Surg. 2015; 47:2:e68e74.
    [Google Scholar]
  7. Vieillard-Baron A, Cecconi M. Understanding cardiac failure in sepsis. Intensive Care Med. 2014; 40:10:15601563.
    [Google Scholar]
  8. Bloch A, Berger D, Takala J. Understanding circulatory failure in sepsis. Intensive Care Med. 2016; 42:12:20772079.
    [Google Scholar]
  9. Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, Schmidt M, Mastroianni C, Chastre J, Leprince P, Anselmi A, Combes A. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med. 2016; 42:3:370378.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2017.swacelso.24
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error